Literature DB >> 30893090

Sarcopenic obesity in fatty liver.

Manuela Merli1, Barbara Lattanzi, Francesca Aprile.   

Abstract

PURPOSE OF REVIEW: Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steato hepatitis have an increasing prevalence among liver diseases. Overweight and obesity are frequently associated conditions in patients with fatty liver. Skeletal muscle mass depletion may also coexist with chronic liver disease even in obese patients. This review will focus on the relationship between sarcopenic obesity and fatty liver. RECENT
FINDINGS: Obesity and sarcopenia are frequently encountered in patients with NAFLD. Adipose tissue is able to release molecules (adipokines) that regulate lipid metabolism, interact with insulin sensitivity and may contribute to induce fibrogenesis in the liver. Skeletal muscle tissue is able to secrete myokines regulating muscle metabolism and insulin sensitivity. Myokines perturbation has been reported to influence adipose tissue mass and fat deposition in the liver. Sarcopenia has been reported as independent risk factor for the development of NAFLD, and for a more severe liver fibrosis in patients with NAFLD.
SUMMARY: The interaction between skeletal muscle, adipose tissue and the liver may play a role in the development of NAFLD. Sarcopenia and sarcopenic obesity are risk factors for the development of fatty liver and associated with more severe liver fibrosis. Management is not standardized, but dietary counseling and physical training have been proposed as promising strategies. Bariatric surgery may be considered in patients with severe 'resistant' obesity.

Entities:  

Mesh:

Year:  2019        PMID: 30893090     DOI: 10.1097/MCO.0000000000000558

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  12 in total

Review 1.  European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline.

Authors:  Stephan C Bischoff; Rocco Barazzoni; Luca Busetto; Marjo Campmans-Kuijpers; Vincenzo Cardinale; Irit Chermesh; Ahad Eshraghian; Haluk Tarik Kani; Wafaa Khannoussi; Laurence Lacaze; Miguel Léon-Sanz; Juan M Mendive; Michael W Müller; Johann Ockenga; Frank Tacke; Anders Thorell; Darija Vranesic Bender; Arved Weimann; Cristina Cuerda
Journal:  United European Gastroenterol J       Date:  2022-08-12       Impact factor: 6.866

2.  A Comparison Study on the Therapeutic Effect of High Protein Diets Based on Pork Protein versus Soybean Protein on Obese Mice.

Authors:  Songsong Jiang; Shanshan Ji; Xinlei Tang; Tao Wang; Hengpeng Wang; Xiangren Meng
Journal:  Foods       Date:  2022-04-24

Review 3.  Nutrition in Chronic Liver Disease.

Authors:  Yala Kirthi Reddy; Benedict Maliakkal; Uchenna Agbim
Journal:  Curr Treat Options Gastroenterol       Date:  2019-12

Review 4.  Physical Exercise and Myokines: Relationships with Sarcopenia and Cardiovascular Complications.

Authors:  Sandra Maria Barbalho; Uri Adrian Prync Flato; Ricardo José Tofano; Ricardo de Alvares Goulart; Elen Landgraf Guiguer; Cláudia Rucco P Detregiachi; Daniela Vieira Buchaim; Adriano Cressoni Araújo; Rogério Leone Buchaim; Fábio Tadeu Rodrigues Reina; Piero Biteli; Daniela O B Rodrigues Reina; Marcelo Dib Bechara
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

Review 5.  Sarcopenic Obesity in Non-Alcoholic Fatty Liver Disease-The Union of Two Culprits.

Authors:  Saad Emhmed Ali; Mindie H Nguyen
Journal:  Life (Basel)       Date:  2021-02-04

Review 6.  The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review.

Authors:  Angelo Armandi; Chiara Rosso; Gian Paolo Caviglia; Davide Giuseppe Ribaldone; Elisabetta Bugianesi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-10       Impact factor: 5.555

7.  Preoperative TIPS prevents the development of postoperative acute-on-chronic liver failure in patients with high CLIF-C AD score.

Authors:  Johannes Chang; Pauline Höfer; Nina Böhling; Philipp Lingohr; Steffen Manekeller; Jörg C Kalff; Jonas Dohmen; Dominik J Kaczmarek; Christian Jansen; Carsten Meyer; Christian P Strassburg; Jonel Trebicka; Michael Praktiknjo
Journal:  JHEP Rep       Date:  2022-01-21

Review 8.  Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?

Authors:  Ivana Mikolasevic; Tajana Pavic; Tajana Filipec Kanizaj; Darija Vranesic Bender; Viktor Domislovic; Zeljko Krznaric
Journal:  Can J Gastroenterol Hepatol       Date:  2020-10-31

Review 9.  Dysregulated Autophagy Mediates Sarcopenic Obesity and Its Complications via AMPK and PGC1α Signaling Pathways: Potential Involvement of Gut Dysbiosis as a Pathological Link.

Authors:  Ji Yeon Ryu; Hyung Muk Choi; Hyung-In Yang; Kyoung Soo Kim
Journal:  Int J Mol Sci       Date:  2020-09-19       Impact factor: 5.923

Review 10.  Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions.

Authors:  Ana Rita de Oliveira Dos Santos; Bárbara de Oliveira Zanuso; Vitor Fernando Bordin Miola; Sandra Maria Barbalho; Patrícia C Santos Bueno; Uri Adrian Prync Flato; Claudia Rucco P Detregiachi; Daniela Vieira Buchaim; Rogério Leone Buchaim; Ricardo José Tofano; Claudemir Gregório Mendes; Viviane Alessandra Capelluppi Tofano; Jesselina F Dos Santos Haber
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.